Abstract NK cell-mediated resistance to viruses is subject to genetic control in humans and mice. Here we used classical and quantitative genetic strategies to examine NK-mediated murine cytomegalovirus (MCMV) control in genealogically related New Zealand white (NZW) and black (NZB) mice. NZW mice display NK cell-dependent MCMV resistance while NZB NK cells fail to limit viral replication after infection. Unlike Ly49H
Introduction
Human cytomegalovirus (HCMV) is a ubiquitous viral pathogen found throughout the world. The Center for Disease Control and Prevention (2006) reports that over 60% of individuals by the age of 40 are infected with HCMV. While most individuals display no overt symptoms of infection, HCMV can pose a serious threat to immunocompromised or immune suppressed individuals (Orange 2002; Rennekampff and Hamprecht 2006) . Moreover, HCMV is the leading cause of congenital birth defects in the United States (Landolfo et al. 2003; Malm and Engman 2007) . An important aim of ongoing research is to elucidate the mechanisms along with the molecular and genetic factors that regulate how the immune system can recognize and respond to CMV infection with effective virus control.
Early resistance to murine CMV (MCMV) infection has been extensively characterized in C57BL/6 mice to study the dominant Ly49H resistance factor and further examine hostpathogen interactions. Recently, we found that early resistance to MCMV infection in New Zealand white (NZW) mice requires NK cells, as do B6 mice. However, NKmediated control in NZW mice is Ly49H-independent (Rodriguez et al. 2004 ). In comparison, we found that NK cells in genealogically related New Zealand black (NZB) mice were unable to restrict MCMV replication; therefore, NZB mice were profoundly susceptible to infection. Genetic comparison of NZW-and NZB-like MCMV control traits in (NZW 9 NZB)F 1 and F 2 progeny revealed that NZW viral resistance was a nondominant trait defined by multiple genetic factors (Rodriguez et al. 2004) . Designated as Cmv2, this NZW MCMV control trait required NK cells, was Ly49H-independent, and exhibited genetic complexity.
Quantitative trait loci (QTL) mapping has been successfully used to identify numerous loci underlying complex genetic traits such as obesity, malaria susceptibility, and osteoporosis (Fortin et al. 2002; Ishimori et al. 2006 Ishimori et al. , 2008 Kumazawa et al. 2007; Stylianou et al. 2006) . Therefore, QTL analysis was used to map loci affecting early spleen MCMV genome levels in New Zealand F 2 offspring. We anticipated that loci in the natural killer gene complex (NKC) on chromosome 6 and/or in the major histocompatibility complex (MHC) on chromosome 17 would be associated with Cmv2. Surprisingly, genetic mapping analyses performed on a (NZW 9 NZB)F 2 (WBF 2 ) data set identified significant QTL residing on chromosome X and outside the MHC on chromosome 17 near genetic markers DXMit216 (139.1 Mb, build 36) and D17Mit152 (65.2 Mb, build 36), respectively (Rodriguez et al. 2004 ). These results suggested that Cmv2 might be linked to loci containing novel MCMV resistance factors.
In this investigation we confirm that the DXMit216 locus impacts MCMV control in New Zealand F 2 mice. Surprisingly though, multiple F 2 cohorts demonstrated that the NZB-derived DXMit216 (DXMit216 nzb ) allele conferred greater MCMV control in male but not in female F 2 offspring. Other genomic loci likely contribute to DXMit216 nzb -linked MCMV control since this locus by itself was not significantly associated with greater MCMV control in New Zealand F 1 or NZW.NZB-DXMit216 congenic males. This study reveals the importance of chromosome X-linked genetic factors in Cmv2 immunity and identifies other potential genomic loci associated with MCMV resistance.
Materials and methods

Mice
NZW/LacJ, NZB/BINJ, and C57BL/6 J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained in the MR5 SPF vivarium at the University of Virginia (UVA), which is fully accredited by the American Association for Accreditation of Laboratory Animal Care. New Zealand F 1 and F 2 mice were bred and maintained at UVA. NZM88, NZM391, NZM2328, and NZM2758 breeders were kindly provided by Dr. David Lawrence. NZW.NZB-DXMit216 and NZW.NZB-H2 d were generated essentially as previously described (Dighe et al. 2005; Xie et al. 2007) . Briefly, NZW.NZB-H2 d and NZW.NZBDXMit216 congenic mice were generated by backcrossing (NZW 9 NZB)F 1 mice with NZW. Backcross offspring with select donor NZB H-2 loci [defined by simple sequence length polymorphism (SSLP) markers D17Mit16-D17Mit10] or chromosome X loci (DXUva03-rs13484113) were further separately backcrossed with NZW through four additional backcross generations. NZW. ) and NZW. ) generation mice were used in experiments. Animal protocols were approved and mouse experiments were conducted in accordance with Animal Care and Use Committee guidelines.
Virus assays
MCMV was propagated by serial passage of salivary gland stock virus (Smith strain, ATCC No. VR194) through weanling BALB/c mice as previously described (Rodriguez et al. 2004) . Experimental MCMV stocks were titered on NIH3T3 monolayers in at least three independent experiments. Mice (8-12 weeks) were intraperitoneally infected with 1 9 10 5 PFU of MCMV. Spleen and liver tissue samples were obtained from infected or control mice 3.5 days after infection. Tissue genomic DNA was isolated using the Puregene DNA isolation kit (Gentra Systems Inc., Minneapolis, MN). MCMV genome levels were quantified using quantitative real-time PCR (qPCR) as previously described (Rodriguez et al. 2004; Wheat et al. 2003) . All sample measurements were performed in triplicate. Spleen and liver MCMV genome levels were reported as the log 10 (number of CMV genome copies/number endogenous b-actin genome copies).
Genotyping and genetic mapping of quantitative trait loci (QTL)
A panel of 84 fluorescent-labeled SSLP markers, including new DXMit216-flanking markers DXUva01 and DXUva03 (Fig. 1) , to distinguish NZW and NZB alleles was used to determine genome-wide genotypes for tissue DNA samples described above. SSLP amplification products were analyzed using the 3130xl genetic analyzer with Data Collection (v3.0) and GeneMapper v4.0 software (Applied Biosystems, Foster City, CA). Interval mapping in R/qtl was calculated using the expectation maximization (EM) algorithm with a normal model on square-root-transformed MCMV trait values and using the nonparametric option. All QTL mapping analyses were performed using the WBF 2 cohort I data set (n = 183). A permutation test (1000 permutations) performed on the WBF 2 data set determined QTL significance thresholds that were applied to the interval mapping analysis.
Statistics
The Mann-Whitney (M-W) nonparametric test was used to compare MCMV genome levels in spleens of infected 
Results
A Cmv2 quantitative trait locus on chromosome X Previously, we examined MCMV control in a cohort of 257 (NZW 9 NZB)F 2 (WBF 2 ) offspring; 119 of the 257 animals were genome-wide genotyped (Rodriguez et al. 2004 ). This analysis was extended to confirm previous genetic linkages to D17Mit152 and DXMit216 by examining 64 additional WBF 2 mice. WBF 2 genomes were genotyped and examined for resistance to MCMV infection as previously described (Rodriguez et al. 2004 ); spleen and liver virus genome levels were assessed using quantitative real-time PCR (qPCR). This extended analysis was composed of MCMV-resistance traits and genome typings for 183 infected WBF 2 mice (referred to as cohort I: 99$, 84#).
The R/qtl genetic mapping program incorporates sex and cross direction information in calculating QTL significance thresholds for chromosome X and the autosomes (Broman et al. 2006) . The identity of the paternal grandmother (NZW) and the sex of each WBF 2 mouse were included in the analysis. Since the MCMV trait values followed a nonnormal distribution (Fig. 2a) , the WBF 2 data set (n = 183) was analyzed with a nonparametric model and also squareroot-transformed trait values. WBF 2 interval mapping with a nonparametric option identified a significant QTL linked with DXMit216 (LOD = 3.18, X-chromosome 95% significance threshold = 2.86) on chromosome X (Fig. 2b) . A suggestive QTL linkage was observed at D10Mit10 on chromosome 10 (LOD = 1.98, autosomal suggestive threshold = 1.92), which had been mapped previously (Rodriguez et al. 2004) . Consistent with the above results, analyses performed with the square-root-transformed trait values (95% significance LOD = 3.11) present a nearly significant QTL at DXMit216 (LOD = 3.02) (Fig. 2b) . Altogether, these findings substantiated a significant QTL near DXMit216 on chromosome X.
Curiously, no chromosome 17 SSLP markers were associated with Cmv2 resistance in these analyses. To support the latter findings, we also examined MCMV control in NZW.NZB-H2 d congenic mice and several New Zealand mixed (NZM) strains, including NZM88, NZM391, NZM2328, and NZM2758 (Fig. 3) . As shown in Fig. 3a , MCMV control in congenic NZW.NZB-H2 d and NZW control mice was comparable. Thus, the MHC was not a significant factor in Cmv2 resistance. In addition, average spleen MCMV genome levels in the NZM strains ranged between those observed in NZW and NZB controls (Fig. 3b) . Because each of the NZM strains inherited chromosome 17 from NZW ( Supplementary Fig. 1 ), this finding further indicated that chromosome 17 loci were unlikely to greatly impact Cmv2 immunity.
Impact of sex on DXMit216-linked Cmv2 resistance
The chromosome X-linked QTL prompted a comparison of average spleen MCMV genome levels for WBF 2 sexsegregated populations (99$, 84#). MCMV trait values Arithmetic mean values for each group are also shown. Student's t test revealed no significant differences in mean spleen MCMV genome levels between NZW and NZW.NZB-H2 d mice. The MannWhitney test in (b) revealed that several mean spleen MCMV genome levels in NZM were significantly higher (*p \ 0.01) than in NZW were continuously distributed among the male and female groups (Fig. 4a) . However, the empirical distribution plots revealed that more WBF 2 males than females had low spleen MCMV (Fig. 4b) . Roughly 40% of males had a CMV:b-actin copy number ratio less than 1.0 compared to only 25% of females. A similar but separate study with a cohort of 75 WBF 2 mice (cohort II) yielded similar results (Supplementary Fig. 2 ). These data indicated that WBF 2 males limited spleen MCMV replication more effectively than females Several strategies were then used to validate DXMit216 linkage with MCMV control in this system. First, cohort I WBF 2 mice were stratified by sex and DXMit216 genotype for comparison of average spleen MCMV genome levels in each group. Since a NZW female was the paternal grandmother of the WBF 2 mouse cross, only DXMit216 nzw or DXMit216 het females and hemizygous (DXMit216 nzw/y or DXMit216 nzb/y ) males were produced (Fig. 5a ). As shown in Fig. 4c , average spleen MCMV genome levels were comparable in DXMit216-stratified females. In contrast, we found that the average MCMV genome level was approximately threefold lower in DXMit216 nzb/y males than in DXMit216 nzw/y males or females. An effect plot generated for DXMit216 from our square-root-transformed data also indicated that a male-specific effect was attributed to chromosome X (Supplementary Fig. 3 ). These data indicated that a DXMit216-linked QTL inherited from NZB restricted MCMV infection in WBF 2 males.
Next, MCMV control in WBF 1 and BWF 1 mice was compared. We hypothesized that genetically identical WBF 1 and BWF 1 females would display comparable MCMV control, whereas BWF 1 (DXMit216 nzb/y ) males should display greater resistance than WBF 1 (DXMit216 nzw/y ) males or females (Fig. 5) . As expected, spleen MCMV genome levels were comparable in F 1 females (Supplementary Fig. 4A ). However, MCMV genome levels in BWF 1 males were not significantly different from other male or female mice ( Supplementary Fig. 4A ). Thus, DXMit216 nzb -linked effects were not observed in F 1 mice. This finding suggested that NZB susceptibility alleles might mask DXMit216 nzb -linked effects on an F 1 background. To circumvent this potential problem, NZW.NZB-DXMit216 congenic mice were generated with the expectation that introgression of the DXMit216 nzb locus onto an NZW genetic background would confer greater MCMV resistance. However, virus control in the congenic males was comparable to that in littermate controls and NZW mice ( Supplementary Fig. 4B ). Thus, DXMit216-linked QTL effects were not apparent when nzb -linked Cmv2 resistance. While traditional approaches to biologically authenticate a DXMit216-linked QTL proved difficult and because its effects were evident only in WBF 2 males, we examined MCMV control in an independent F 2 cohort outcrossed in the opposite (NZB 9 NZW)F 2 (BWF 2 ) genetic direction (Fig. 5b) . We hypothesized that BWF 2 DXMit216 nzb females and DXMit216 nzb/y males would display effective MCMV control. As shown in Fig. 6a , spleen MCMV genome levels were discontinuously distributed in sexsegregated BWF 2 offspring, including 16 males and 4 females with virus levels much lower than in all other BWF 2 animals. It was unlikely that technical error could explain this outcome since most infected animals lost more than 5% body weight, including mice with very low spleen MCMV (Fig. 7b, c) . These body weight changes were consistent with those routinely observed in inbred controls ( Fig. 7a) and differed from that of uninfected mice whose body weights were unaffected (data not shown). Interestingly, a greater proportion of male offspring contained significantly lower spleen MCMV levels than females (Fig. 6a, b) .
Since DXMit216 nzb/y males had lower mean spleen MCMV genome levels than all other WBF 2 groups (Fig. 4c) , a similar comparative analysis was performed after BWF 2 offspring were stratified by sex and DXMit216 genotype. Here, WBF 2 and BWF 2 data sets were analyzed separately because mice in the different cohorts were infected with distinct virus stock preparations given at different times and in different locations. Moreover, genomewide genotype profiles were ascertained for only cohort I WBF 2 offspring. Despite these caveats, we found low-viruscontaining males in both DXMit216-segregated groups. Although not statistically significant, roughly 25% of DXMit216 nzb/y males displayed a low-virus phenotype compared with only 15.3% of DXMit216 nzw/y males (Fig. 6c) males contain a greater proportion of animals with low MCMV (Fig. 6d) . Thus, DXMit216-linked effects also significantly contributed MCMV resistance in BWF 2 males. Although the DXMit216 het female population also contained animals with low MCMV, their trait value distributions were comparable to those of DXMit216 nzb females (Fig. 6e) . We conclude that a DXMit216 nzb -linked QTL affects Cmv2 immunity in F 2 male progeny.
Statistical analysis of WBF 2 and BWF 2 cohort data
We next assessed whether the WBF 2 and BWF 2 MCMV trait value distributions actually differed. As shown in Fig. 8 , empirical distribution plots comparing MCMV trait value distributions for females and males revealed significant differences between the F 2 cohorts. Thus, a greater proportion of WBF 2 cohort II offspring had trait values that were lower than a given virus control trait value (e.g., 1.0) than did WBF 2 cohort I or BWF 2 offspring (Fig. 8a, b) . On the other hand, a greater proportion of BWF 2 offspring had higher trait values than offspring of either WBF 2 cohort (Fig. 8) . Although the MCMV genome levels differed between cohorts, this did not impact the differences between males and females as no significant interaction effect was found using the F test (p = 0.44, data not shown), corroborating our previous sex-segregated comparisons. When the data from the three F 2 cohorts were combined and analyzed using a two-way ANOVA test, the trait value distributions again differed significantly for males and females (p \ 0.001, data not shown). We therefore conclude that New Zealand F 2 males controlled early MCMV infection more efficiently than females and this was attributed in part to a DXMit216 nzb -linked QTL. The impact of NZW resistance factors on MCMV control was still apparent in WBF 2 offspring. Comparison of sex-segregated trait value distributions for all three New Zealand F 2 cohorts revealed that the WBF 2 cohorts had a greater proportion of low-virus-containing animals than the BWF 2 cohort (Fig. 8a, b) . For example, 65 and 30% of WBF 2 cohort I and II females, respectively, had trait values lower than the CMV:b-actin ratio of 1.0. In contrast, less than 10% of BWF 2 females had trait values less than 1.0. A similar trend was seen for BWF 2 males. These data suggested that NZW female progenitors transferred unknown MCMV control factors to their WBF 1 and WBF 2 offspring, endowing WBF 2 progeny with more efficient MCMV control than their BWF 2 counterparts.
Discussion
Our studies confirm that a Cmv2 QTL linked to DXMit216 affects early MCMV control in New Zealand F 2 offspring. Cmv2 bears several features that clearly distinguish it from other MCMV control loci, including Cmv1 (Ly49H), Cmv3 (Ly49P), and Cmv4 (an unknown Ly49 pwk receptor?). A major difference in the New Zealand system is the lack of genetic evidence to support NKC or MHC linkage in the current study of three independent F 2 cohorts. Cmv2 was instead marked by continuously distributed trait values in New Zealand F 1 and F 2 progeny and significant genetic linkage has so far been mapped only to DXMit216. Despite not having validated a DXMit216 QTL through use of traditional congenic approaches, analysis of multiple F 2 genetic crosses confirmed its existence amid additional potential modifier gene(s) on the NZB background that might inhibit its function.
Given that a DXMit216-linked effect(s) was most evident in F 2 males, we speculated that body weight Fig. 7 Assessment of body weight change in BWF 2 offspring during acute MCMV infection. Shown are the percent body weight changes in a 3.5-day interval plotted against MCMV control trait values for infected NZW (empty) and NZB (filled) control mice (a), BWF 2 females (b), and BWF 2 males (c) Fig. 8 Comparison of MCMV control trait value distributions among three independent New Zealand F 2 cohorts. The proportion of WBF 2 cohorts I (green) and II (blue) and BWF 2 (red) females (a) and males (b) with less than a given MCMV trait value is plotted. Statistical comparisons of MCMV control trait value distributions by cohort were performed using the Mann-Whitney and F tests. p values are shown and represent the p values obtained for all cohort comparisons differences among males and females might explain the differences in MCMV control. Indeed, several QTL affecting body weight have been mapped to chromosome X. A major X-linked QTL (26.4 cM) associated with the capacity to efficiently convert feed into body mass has been shown to affect males and females (Liu et al. 2001) . Its location on chromosome X apparently coincides with another body weight QTL designated Bw1 (Dragani et al. 1995 ), yet these loci are a great distance from DXMit216. Another X-linked QTL associated with body weight, Bw3, has been mapped to the same chromosome interval as Cmv2 (Dragani et al. 1995) . Although we compared initial body weights with early MCMV control to delineate any potential associations, no correlation was found (data not shown). Furthermore, as shown in Fig. 7 , we observed substantial body weight losses in males and females after MCMV infection that was independent of their spleen MCMV genome levels. Hence, it is unlikely that the DXMit216-linked QTL coincides with Bw3.
Several interesting loci linked to DXMit216 include mouse KIR-like (KIRL) sequences Kirl1, Kirl2 (Kir3dl2), and Kir3dl1 (Welch et al. 2003) , which resemble killer immunoglobulin-like receptors (KIR), some of which bind MHC class I molecules as their ligands. When displayed by NK cells in human and other species, KIRs conduce NK cell self-tolerance, recognition of cellular targets, and control of NK effector functions. Ly49 lectin-like NK cell receptors also bind MHC class I molecules and serve an analogous functional role in mice. Interestingly, KIR and Ly49 gene families have separately expanded in a polarized fashion in NK receptor gene complexes in human and mouse genomes, respectively (Kelley et al. 2005) . In fact, only a single Ly49 pseudogene has been found within the human NK gene complex (NKC) on chromosome 12. Human KIR genes reside in the leukocyte receptor complex (LRC) on chromosome 19. Mouse Ly49 genes reside on chromosome 6 in the NKC and the mouse LRC on chromosome 7 lacks KIR gene sequences (Kelley et al. 2005) . Altogether, these features hinted that combined expression of KIR and Ly49 receptors might be incompatible or even detrimental. This speculation, however, has been proved incorrect since several mammalian species express both KIR and Ly49 receptors (Brown and Scalzo 2008; Kelley et al. 2005) .
It is somewhat curious that KIRL sequences are absent from the corresponding region on human chromosome X given that KIRL-flanking genes are conserved in human and mouse (Wilson et al. 2007) . A distinct possibility is that an ancestral mouse KIR translocated to chromosome X and evolved to serve a role other than MHC class I surveillance (Wilson et al. 2007 ). Nonetheless, KIRL1 transcripts have been detected in CD44
? CD25 -thymocytes and IL-2-activated NK cells (Welch et al. 2003) . Recently, KIRL1 protein was detected on the surface of BALB/c NK cells with the anti-KIRL1 mAb 6G10 (Wilson et al. 2007 ). Kir3dl1 encodes an inhibitory NK receptor that likely represents an allele of kirl1 expressed in some inbred mouse strains (Hoelsbrekken et al. 2003; Wilson et al. 2007 ). Thus, these DXMit216-linked genes could potentially impact innate immune responses toward viruses and represent sensible positional candidates for a Cmv2 QTL on chromosome X. Formal studies are underway to evaluate whether any of these candidate genes display polymorphisms or differences in gene expression between NZW and NZB mice.
In conclusion, Cmv2 is a complex genetic trait defined by multiple genetic factors, including a chromosome X-linked QTL near DXMit216. Enhanced MCMV resistance in New Zealand F 2 males was conferred by a DXMit216 nzb allele whose effects are likely impacted by an additional gene(s) on the NZB background. Detection of a DXMit216 nzb -linked effect(s) in multiple independent New Zealand F 2 crosses provided us with QTL linkage confirmation consistent with the guidelines of the complex trait consortium that was comparable to selective (genotype-or phenotype-driven) congenic breeding approaches (Abiola et al. 2003) .
